Literature DB >> 3424333

HLA and Graves' disease in Koreans.

B Y Cho1, B D Rhee, D S Lee, M S Lee, G Y Kim, H K Lee, C S Koh, H K Min, M Lee.   

Abstract

The HLA-A, B, C and DR antigen distribution in 128 Korean patients with Graves' disease was compared with that in 220 controls. The frequency of HLA-B13, DR5 and DRw8 (relative risk 3.8, 4.4, and 2.3, respectively) was significantly increased in patients with Graves' disease. There was no significant correlation between the presence of these HLA antigens and the clinical features.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3424333     DOI: 10.1111/j.1399-0039.1987.tb01607.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

1.  Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles.

Authors:  Pei-Lung Chen; Cathy Shen-Jang Fann; Chen-Chung Chu; Chien-Ching Chang; Su-Wei Chang; Hsin-Yi Hsieh; Marie Lin; Wei-Shiung Yang; Tien-Chun Chang
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

2.  Association of Polymorphisms in Toll-Like Receptors 4 and 9 with Autoimmune Thyroid Disease in Korean Pediatric Patients.

Authors:  Won Kyoung Cho; Jung-Pil Jang; Eun-Jeong Choi; Moonbae Ahn; Shin Hee Kim; Kyoung Soon Cho; So Hyun Park; In Cheol Baek; Min Ho Jung; Tai-Gyu Kim; Byung-Kyu Suh
Journal:  Int J Endocrinol       Date:  2017-08-20       Impact factor: 3.257

3.  GPR174 and ITM2A Gene Polymorphisms rs3827440 and rs5912838 on the X chromosome in Korean Children with Autoimmune Thyroid Disease.

Authors:  Won Kyoung Cho; Hye-Ri Shin; Na Yeong Lee; Seul Ki Kim; Moon Bae Ahn; In-Cheol Baek; Tai-Gyu Kim; Byung-Kyu Suh
Journal:  Genes (Basel)       Date:  2020-07-27       Impact factor: 4.096

4.  Case Report: A Rare Case of Coexisting of Autoimmune Polyglandular Syndrome Type 3 and Isolated Gonadotropin-Releasing Hormone Deficiency.

Authors:  Qiuhui Jiang; Ting Wu; Yuxian Zhang; Shunhua Wang; Liying Wang; Weijuan Su; Mingzhu Lin; Xuejun Li
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.